SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $608,251 | +355.6% | 12,936 | +306.5% | 0.06% | +75.0% |
Q1 2023 | $133,517 | +13251.7% | 3,182 | +15052.4% | 0.03% | – |
Q3 2022 | $1,000 | – | 21 | +600.0% | 0.00% | – |
Q2 2022 | $0 | – | 3 | +200.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 1 | -98.6% | 0.00% | -100.0% |
Q3 2021 | $3,000 | -80.0% | 74 | -71.3% | 0.00% | -83.3% |
Q2 2021 | $15,000 | – | 258 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |